Cardiometabolic Disease / Chronic Kidney Disease
Indication
Chronic Kidney Disease
Assets addressing this indication.
Total attributable cost
$646.5B
$17,472/patient
Drug spend
$50.3B
$1,359/patient
8% of total cost is drugs
All stages, non-dialysis (national surveillance estimate, updated 2026-03) · US